BMC Musculoskeletal Disorders

official impact factor 1.94

Open Access Email this article to a friend

Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study

Guillem Cuatrecasas*, Cristina Riudavets, Maria A Güell and Albert Nadal

BMC Musculoskeletal Disorders 2007, 8:119 doi:10.1186/1471-2474-8-119

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.